First Bank & Trust decreased its position in Amgen Inc. (NASDAQ:AMGN - Free Report) by 22.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,535 shares of the medical research company's stock after selling 2